IBDXvsMBB
iShares iBonds Dec 2032 Term Corporate ETF against iShares MBS ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBDX | MBB | |
|---|---|---|
| Expense ratio | 0.10% | 0.040% |
| Assets | $1.7B | $39B |
| Net flow, 1 month | +$44M | +$26M |
| Net flow, 1 year | +$547M | −$1B |
| Return, YTD | -2.4% | -1.7% |
| Return, 1 year | -1.8% | +0.1% |
| Avg daily volume | 229K | 2.3M |
| Holdings | 318 | 10895 |
| Listed | Jun 27, 2022 | Mar 12, 2007 |
| Options market | No | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS